Xue Jing, M.D., Ph.D.

Position:Vice Chair of Rheumatology

Department:Rheumatology

Medical School:Peking Union Medical College, China

Academic Rank:Chief Phyisician


Appointment

Clinical / Research Interests

Diagnosis and treatment of autoimmune diseases and rheumatic diseases, especially connective tissue diseases related interstitial lung diseases, systemic sclerosis.

Professional Highlights

Outstanding Teacher of Zhejiang University, First Prize

Professional Appointments

President-Elect, Zhejiang Society of Rheumatology, 2020-present


Education Experience

Research Summary

Dr. Xu is engaged in the clinical, scientific research and teaching of rheumatic diseases, and has expertise in the research fields of autoimmune diseases, dendritic cells, and connective tissue diseases related interstitial lung diseases.

Publications

Du Y, Nie L, Xu L, Wu X, Zhang S, Xue J*. Serum levels of soluble programmed death protein (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: association with activity and severity. Scand J Immunol. 2020 Apr 3. 

Wu X, Xu L, Cheng Q, Nie L, Zhang S, Du Y*, Xue J*. Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study. Respir Med. 2020 Mar 28;166:105948. 

Zhang T, Yuan F, Xu L, Sun W, Liu L, Xue J*. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression. Clin Rheumatol. 2020 Jan 5;10.1007/s10067-019-04906-6.

Nie LY, Wang XD, Zhang T, Xue J*. Cardiac complications in systemic sclerosis:early diagnosis and treatment. Chin Med J (Engl). 2019 Dec 5;132(23):2865-2871.

Sun W, Zhang T, Wu H, Xue J*. A 32-year-old female with relapsing polychondritisand common variable immunodeficiency due to a monogenic mutation in NFKB2. Rheumatology (Oxford). 2019 Dec 24;kez614. 

Zhang T, Sun W, Xue J, Chen J, Jiang Q, Mou L, Du H. Podocytic infolding glomerulopathy: two new cases with connective tissue disease and literature review. Clin Rheumatol. 2019 May;38(5):1521-1528. 

Wo Yao, Jing Xue*. Widespread nocardiosis in a patient with refractory ANCA-associated vasculitides: relapse or mimics? A case report and literature review. Int J Clin Exp Med 2019;12(6):7878-7886. 

Du Y, Sun F, Zhou M, Wu X, Sun W, Jiang Y, Cheng Q, Chen X, Wu H*, Xue J*. The expression and clinical significance of different forms of LILRA3 in systemic lupus erythematosus. Clin Rheumatol. 2019;38(11):3099–3107. 

Wu H#, Shen J#, Liu L#, Lu X, Xue J*. Vasoactive intestinal peptide-induced tolerogenic dendritic cells attenuated arthritis in experimental collagen-induced arthritic mice. Int J Rheum Dis. 2019;22(7):1255–1262. 

Sun W#, Tian L#, Jiang L, Zhang S, Zhou M, Zhu J, Xue J*. Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis. Clin Rheumatol. 2019;38(4):989–995.  


Current Program

Research on IL-6 antagonist by inhibiting endothelial-to-mesenchymal transition (EndoMT) against systemic sclerosis vascular endothelial injury. Funding Source: General Project of Zhejiang Province Medicine and Health Science and Technology Program.

Find People

Search by Family Name

Find A Department

Search by Departments